Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Regulating B-cell activation and survival in response to TLR signals.

Gerondakis S, Grumont RJ, Banerjee A.

Immunol Cell Biol. 2007 Aug-Sep;85(6):471-5. Epub 2007 Jul 17. Review.

PMID:
17637697
2.
3.

Transducing signals from antigen receptors to nuclear factor kappaB.

Ruland J, Mak TW.

Immunol Rev. 2003 Jun;193:93-100. Review.

PMID:
12752674
4.

Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.

Muzio M, Scielzo C, Bertilaccio MT, Frenquelli M, Ghia P, Caligaris-Cappio F.

Br J Haematol. 2009 Feb;144(4):507-16. doi: 10.1111/j.1365-2141.2008.07475.x. Epub 2008 Nov 19.

PMID:
19036098
5.

Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.

Carmody RJ, Chen YH.

Cell Mol Immunol. 2007 Feb;4(1):31-41. Review.

6.

Tolls for B cells.

Fillatreau S, Manz RA.

Eur J Immunol. 2006 Apr;36(4):798-801. Review.

7.

CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation.

Manjarrez-Orduño N, Moreno-García ME, Fink K, Santos-Argumedo L.

Eur J Immunol. 2007 Feb;37(2):358-67.

8.

The role of Rel/NF-kappaB transcription factors in B lymphocyte survival.

Gerondakis S, Strasser A.

Semin Immunol. 2003 Jun;15(3):159-66. Review.

PMID:
14563114
9.

Superantigen- and TLR-dependent activation of tonsillar B cells after receptor-mediated endocytosis.

Jendholm J, Mörgelin M, Perez Vidakovics ML, Carlsson M, Leffler H, Cardell LO, Riesbeck K.

J Immunol. 2009 Apr 15;182(8):4713-20. doi: 10.4049/jimmunol.0803032.

10.

EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity.

Wang H, Nicholas MW, Conway KL, Sen P, Diz R, Tisch RM, Clarke SH.

J Immunol. 2006 Sep 1;177(5):2793-802.

11.

Toll-like receptors and innate immunity in B-cell activation and antibody responses.

Lanzavecchia A, Sallusto F.

Curr Opin Immunol. 2007 Jun;19(3):268-74. Epub 2007 Apr 12. Review.

PMID:
17433875
12.

Signaling in B cells via Toll-like receptors.

Peng SL.

Curr Opin Immunol. 2005 Jun;17(3):230-6. Review.

PMID:
15886111
13.

Porin of Shigella dysenteriae directly promotes toll-like receptor 2-mediated CD4+ T cell survival and effector function.

Biswas A, Banerjee P, Biswas T.

Mol Immunol. 2009 Sep;46(15):3076-85. doi: 10.1016/j.molimm.2009.06.006. Epub 2009 Jul 2.

PMID:
19576636
14.

Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.

Kobayashi T, Takahashi K, Nagai Y, Shibata T, Otani M, Izui S, Akira S, Gotoh Y, Kiyono H, Miyake K.

Int Immunol. 2008 Jul;20(7):881-91. doi: 10.1093/intimm/dxn049. Epub 2008 May 19.

15.

MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit.

Ferch U, zum Büschenfelde CM, Gewies A, Wegener E, Rauser S, Peschel C, Krappmann D, Ruland J.

Nat Immunol. 2007 Sep;8(9):984-91. Epub 2007 Jul 29.

PMID:
17660823
16.

Extracellular calcium sensing promotes human B-cell activation and function.

Hammond CM, White D, Tomic J, Shi Y, Spaner DE.

Blood. 2007 Dec 1;110(12):3985-95. Epub 2007 Aug 27.

17.

Toll-like receptors: lessons to learn from normal and malignant human B cells.

Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C, Bataille R, Jego G.

Blood. 2008 Sep 15;112(6):2205-13. doi: 10.1182/blood-2008-02-140673. Epub 2008 Jun 30. Review.

18.

The follicular versus marginal zone B lymphocyte cell fate decision.

Pillai S, Cariappa A.

Nat Rev Immunol. 2009 Nov;9(11):767-77. doi: 10.1038/nri2656. Review.

PMID:
19855403
19.

TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway.

Moynagh PN.

Trends Immunol. 2005 Sep;26(9):469-76. Review.

PMID:
16006187
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk